More than 5,000 Down Syndrome biospecimens. Available now.

5,000+ Aliquots. Housed at Cincinnati Children's. No recruitment delays.

The DSA Biobank is a specialty biorepository dedicated exclusively to Down syndrome — providing researchers with immediate access to broadly consented biospecimens, structured family cohorts, and samples available without the delays of independent recruitment. Housed at Cincinnati Children’s Hospital Medical Center, our inventory of 5,000+ aliquots is ready to support your next study.

Institutional-Grade Processing & Storage

All DSA Biobank biospecimens are processed and stored at Cincinnati Children’s Hospital Medical Center — consistently ranked among the top children’s hospitals in the U.S. and a leading recipient of NIH pediatric research funding. CCHMC’s institutional biobanking infrastructure ensures samples meet the quality standards required for publication and regulatory submission.

Research Areas We Support

DSA Biobank samples support basic, translational, and clinical research across the conditions most prevalent in Down syndrome:

  • Alzheimer’s disease and neurodegeneration
  • Leukemia and blood disorders
  • Congenital heart defects
  • Autoimmune disease
  • Keratoconus and ocular conditions
  • Thyroid and metabolic disorders

If your study involves any of these areas, our samples may be a fit. Submit a brief research summary and our team will confirm feasibility within one week.

Funding for Down Syndrome Research

Down syndrome research is at an inflection point — and funding is following. NIH’s INCLUDE Project is actively funding DS research across Alzheimer’s, congenital heart disease, autoimmune conditions, and more. DSA is committed to reducing the remaining barriers that slow investigators down — starting with sample access.

Pricing

DSA Biobank operates on a cost-recovery model, keeping pricing accessible for academic and investigator-initiated research. Base pricing starts at $200/aliquot for serum and plasma, and $250/aliquot for DNA.

Pharmaceutical and biotechnology companies are encouraged to contact us directly to discuss study scope and pricing.

Skip to content